**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 846-70-8 |Naphthol Yellow S | 98 | 212-690-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38 68
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Possible risk of
irreversible effects.The toxicological properties of this material
have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. The toxicological properties of this
substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Harmful if inhaled.
Chronic:
May cause anemia and other blood cell abnormalities.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Dangerous
fire hazard in the form of dust when exposed to heat or flame.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 846-70-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: yellow or orange
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 91 deg C (> 195.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: slightly soluble
Specific Gravity/Density:
Molecular Formula: C10H4N2O8SNa2
Molecular Weight: 358.19
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, heating to decomposition.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 846-70-8: QK1813000
LD50/LC50:
Not available.
Carcinogenicity:
Naphthol Yellow S -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 68 Possible risk of irreversible effects.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 846-70-8: 1
Canada
CAS# 846-70-8 is listed on Canada's DSL List.
CAS# 846-70-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 846-70-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/10/1998 Revision #5 Date: 10/06/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Tetrachlorocyclopropene, 98% (GC)
| 6262-42-6 |
|
Analgin DAB
| 68-89-3 |
|
Chelidonic Acid Monohydrate, 96%
| 6003-94-7 |
|
2-Chloro-4-Nitrotoluene, 99%
| 121-86-8 |
|
3-Methoxyphenyl isocyanate, 99%
| 18908-07-1 |
|
Cyclododecylmethyl ether, 98+%
| 2986-54-1 |
|
3-Bromofluorobenzene, 99%
| 1073-06-9 |
|
Gallium atomic absorption standard solution, 1mg/ml Ga in 2% HNO3
| 7440-55-3 |
|
Triacetylmethane, 97%
| 815-68-9 |
|
(4-Pyridylthio)Acetic Acid , 98%
| 10351-19-6 |
|
2-Methyl-1-Nitronaphthalene, 99%
| 881-03-8 |
|
Adogen 464
| 63393-96-4 |
|
Trichloroacetonitrile, 95% (gc)
| 545-06-2 |
|
Methyl orotate, 99%
| 6153-44-2 |
|
5-Amino-6-nitroquinoline, 98%
| 35975-00-9 |
|
Ammonium Sulfobetaine - 4, 1 % Solution in Water
| |
|
3-Fluoro-p-anisaldehyde, 99%
| 351-54-2 |
|
3,5-Dibenzyloxyacetophenone, 98%
| 28924-21-2 |
|
Triisopropylsilane
| 6485-79-6 |
|
Ethyl Cis-2-Hydroxy-1-Cyclopentanecarboxylate, 98%
| 2315-21-1 |
|
Acetol, tech., ca 90-95% (gc)
| 116-09-6 |
|
Bathocuproinedisulfonic acid,disodium salt hydrate, 97% (hplc)
| 52698-84-7 |
|
Glycerol-1-Allylether, 98%
| 123-34-2 |
|
Dimethylamine Hydrochloride, 99% (Dry Substance)
| 506-59-2 |
|
Sodium tetrathionate, 90% (titr.)
| 10101-86-7 |
|
1,4-Diiodobenzene, 98%
| 624-38-4 |
|
Dibromomaleic Acid
| 608-37-7 |
|
1(and 2)-Octene, 99% (GC)
| 62758-15-0 |
|
3-Isobutoxy-2-cyclohexen-1-one, 99%
| 23074-59-1 |
|
2,4,5-Tribromoimidazole, 97%
| 2034-22-2 |
|
6-Nitrobenzimidazole, 98%
| 94-52-0 |
|
Acid blue 120
| 3529-01-9 |
|
2,6-Dimethylquinoline, 98%
| 877-43-0 |
|
3-Diethylamino-1-propanol, 94% (titr.)
| 622-93-5 |
|
FMOC-Beta-Alanine, 98%
| 35737-10-1 |
|
2-Chlorocyclopentanone, 97% (Stabilzed with 200 ppm H.Q.)
| 694-28-0 |
|
2-Azacyclononanone 99%
| 935-30-8 |
|
Diethylamine Hydrochloride, 99%
| 660-68-4 |
|
Tetrabutylammonium Nitrate
| 1941-27-1 |
|
2,4-Di-Tert-Pentylphenol, 96% (GC)
| 120-95-6 |
|
1-Diazo-2-naphthol-4-sulfonic acid,97%(TLC, contains ca. 25%
| 887-76-3 |
|
tert-Butylurea
| 1118-12-3 |
|
5-Acetoxymethyl-2-furaldehyde
| 10551-58-3 |
|
Iodoethane-d5, 99+ atom% d
| 6485-58-1 |
|
Dimethyldithiocarbamic Acid Sodium Salt
| 128-04-1 |
|
Naphthol yellow s
| 846-70-8 |
|
Molecular Sieves, 13X, Powder (< 0.050 mm)
| 0-00-1 |
|
1,2-Octanediol, 98+%
| 1117-86-8 |
|
Tetrahexylammonium Benzoate
| 16436-29-6 |
|
4-Bromophenylhydrazine Hydrochloride, 99%
| 622-88-8 |
|
|